ADVERTISEMENT
Oncology Innovations
Episode 1 Continued: The Value and Opportunity in Individualized Cancer Care: Part 2
12/01/2021
In this 2-part series, Gordon Kuntz, Kuntz Consulting, interviews Bryan Loy, MD, MBA, Physician Lead for Oncology, Laboratory, and Personalized Medicine at Humana, and Tushar Pandey, MBA, CEO of SimBioSys, about the value and opportunity in individualized cancer care.
In the second installment, Gordon, Dr Loy, and Tushar discuss the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
June 2024
Volume 10
Issue 3
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Journal of Clinical Pathways Newsletter
Advertisement
Advertisement
Advertisement
Recent Stories
Advertisement